https://www.avient.com/sites/default/files/2022-08/Avient Candidates Data Privacy Notice Final - Dutch.pdf
Indien u zich in de EU of het VK bevindt, geldt de overeenkomst voor internationale gegevensoverdracht
binnen de bedrijvengroep (Intra Group International Data Transfer Agreement) die Avient is aangegaan.
https://www.avient.com/sites/default/files/2020-10/light-diffusion-case-study.pdf
Despite
using an acrylic sheet with built-in light diffusion
technology, the light source was plagued by visual
“hot spots.”
Also,
the acrylic sheets required an additional process to
cut them to size before thermoforming, which led to
excessive waste and disposal costs.
Instead of purchasing pre-fabricated acrylic
sheet that contained a costly diffusion additive, the
Smartbatch solution enabled the customer to reduce its
material costs by 50%.
https://www.avient.com/sites/default/files/resources/Gabelli%2520Conf%2520-%2520POL%2520IR%2520Presentation%2520wNon%2520GAAP%2520Reconciliation%252003%252026%252015.pdf
S&P 500
All time high of
$43.34
July 1st, 2014
PolyOne Corporation Page 9
2006 2014 2015 Target
“Where we were” “Where we are” (Est. in 2012)
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 14.7% 12 – 16%
Global Specialty Engineered
Materials 1.1% 12.1% 12 – 16%
Designed Structures & Solutions 1.4% (2012) 7.3% 8 – 10%
Performance Products &
Solutions 5.5% 7.7% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 65% 65 – 75%
3) ROIC* 5.0% 11.3% 15%
4) Adjusted EPS Growth N/A 37% Double Digit
Expansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Proof of Performance & 2015 Goals
PolyOne Corporation Page 10
Continuing Earnings Growth
Double
Digit EPS
Expansion
Ongoing LSS
Programs
Incremental
Share
Buybacks
Mergers &
Acquisitions
Continued
Gross
Margin
Expansion
Mid Single
Digit
Revenue
Growth
Accelerated
Innovation &
Mix
Improvement
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
60%
94%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of December 31, 2014
Debt Maturities & Pension Funding – 12/31/14
Net Debt / EBITDA* = 1.9x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of December 31, 2014
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 12/31/2014
PolyOne Corporation Page 14
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
(including synergy
capture)
~75% of capital
expenditures fund
growth initiatives
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
• Operating Margin
Synergy opportunities
Adjacent material
solutions
Repurchased 1.6
million shares in Q4
2014
Repurchased 11.3
million shares since
early 2013
8.7 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 15
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 16
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
Gabelli Conf - POL IR Presentation
��PolyOne Investor Presentation�Gabelli Specialty Chemicals Conference�March 2015��
Forward-Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Confirmation of Our Strategy
Strategy and Execution Drive Results
Proof of Performance & 2015 Goals
Continuing Earnings Growth
Innovation Drives Earnings Growth
Megatrends Aligned with Key End Markets
Debt Maturities & Pension Funding – 12/31/14
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
PolyOne Core Values
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
Strong past performance demonstrates that our
strategy and execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation
and competitive advantage
• Strong and proven management team driving
growth and performance
• Addressable market exceeds $40 billion
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Page 15
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and
presented in accordance with U.S.
Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9
Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7
Platform sales and operating income (OI) H1 2012*** H1 2013***
Global Specialty Engineered Materials Sales $ 280.9 $ 352.0
Global Color, Additives and Inks Sales 413.9 434.7
Designed Structures & Solutions Sales - 240.4
Specialty Platform Sales 694.8 1,027.1
Performance Products and Solutions Sales 336.0 336.7
PolyOne Distribution Sales 533.6 543.1
Corporate and Eliminations (62.3) (68.2)
Total Sales $ 1,502.1 $ 1,838.7
Global Specialty Engineered Materials OI $ 24.6 $ 32.5
Global Color, Additives and Inks OI 44.0 54.7
Designed Structures & Solutions OI - 10.5
Specialty Platform OI $ 68.6 $ 97.7
Performance Products and Solutions OI 19.3 27.5
PolyOne Distribution OI 33.4 33.1
Corporate and eliminations (20.3) (25.7)
Special items in OI (20.3) (11.4)
Operating income - GAAP $ 80.7 $ 121.2
Special items in OI 20.3 11.4
Operating income adjusted $ 101.0 $ 132.6
Global Specialty Engineered Materials - OI % of sales
8.8% 9.2%
Global Color, Additives and Inks - OI % of sales 10.6% 12.6%
Designed Structures & Solutions – OI % of sales - 4.4%
Specialty platform OI % of sales 9.9% 9.5%
PP&S operating OI % of sales 5.7% 8.2%
Distribution OI % of sales 6.3% 6.1%
PolyOne OI adjusted, % of sales 6.7% 7.2%
Reconciliation to Condensed Consolidated Balance Sheets H1 2013
Short-term debt and current portion of long-term debt $ 8.7
Long-term debt 1,022.5
Less cash and cash equivalents (392.4)
Specialty Platform Gross Margin Percentage 2006Y* Q2 2013****
Global Specialty Engineered Materials Sales $ 345.3 $ 143.5
Global Color, Additives and Inks Sales 531.8 207.5
Specialty Platform Sales $ 877.1 $ 351.0
Global Specialty Engineered Materials Gross Margin $ 41.6 37.3
Global Color, Additives and Inks Gross Margin 83.6 71.8
Specialty Platform Gross Margin $ 125.2 $ 109.1
Specialty Platform Gross Margin Percentage 14.3% 31.1%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
August 13 - Jefferies 2013 Investor Presentation non-GAAP v2 (2).pdf
Reconciliation to Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/resources/POL%2520Credit%2520Suisse%2520IR%2520Presentation%2520w%2520non-GAAP%25209%252017%25202013.pdf
Strong past performance demonstrates that our
strategy and execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation
and competitive advantage
• Strong and proven management team driving
growth and performance
• Addressable market exceeds $40 billion
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Page 15
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and
presented in accordance with U.S.
Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9
Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average
PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7
Platform sales and operating income (OI) H1 2012*** H1 2013*** H1 2013****
Global Specialty Engineered Materials Sales $ 280.9 $ 352.0 $ 285.1
Global Color, Additives and Inks Sales 413.9 434.7 409.2
Designed Structures & Solutions Sales - 240.4 -
Specialty Platform Sales $ 694.8 $ 1,027.1 $694.3
Performance Products and Solutions Sales 336.0 336.7 317.5
PolyOne Distribution Sales 533.6 543.1 543.1
Corporate and Eliminations (62.3) (68.2) (68.2)
Total Sales $ 1,502.1 $ 1,838.7 $ 1,486.7
Global Specialty Engineered Materials OI $ 24.6 $ 32.5 $ 31.2
Global Color, Additives and Inks OI 44.0 54.7 52.0
Designed Structures & Solutions OI - 10.5 -
Specialty Platform OI $ 68.6 $ 97.7 $ 83.2
Performance Products and Solutions OI 19.3 27.5 25.7
PolyOne Distribution OI 33.4 33.1 33.1
Corporate and eliminations (20.3) (25.7) (20.3)
Special items in OI (20.3) (11.4) (20.3)
Operating income - GAAP $ 80.7 $ 121.2 $ 101.4
Special items in OI 20.3 11.4 20.3
Operating income adjusted $ 101.0 $ 132.6 $ 121.7
Global Specialty Engineered Materials - OI % of sales
8.8% 9.2% 10.9%
Global Color, Additives and Inks - OI % of sales 10.6% 12.6% 12.7%
Designed Structures & Solutions - OI % of sales - 4.4% -
Specialty platform - OI % of sales 9.9% 9.5% 12.0%
PP&S operating - OI % of sales 5.7% 8.2% 8.1%
Distribution OI - % of sales 6.3% 6.1% 6.1%
PolyOne OI adjusted - % of sales 6.7% 7.2% 8.2%
Reconciliation to Condensed Consolidated Balance Sheets H1 2013
Short-term debt and current portion of long-term debt $ 8.7
Long-term debt 1,022.5
Less cash and cash equivalents (392.4)
Specialty Platform Gross Margin Percentage 2006Y* Q2 2013****
Global Specialty Engineered Materials Sales $ 345.3 $ 143.5
Global Color, Additives and Inks Sales 531.8 207.5
Specialty Platform Sales $ 877.1 $ 351.0
Global Specialty Engineered Materials Gross Margin $ 41.6 $ 37.3
Global Color, Additives and Inks Gross Margin 83.6 71.8
Specialty Platform Gross Margin $ 125.2 $ 109.1
Specialty Platform Gross Margin Percentage 14.3% 31.1%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
Credit Suisse September 2013 Investor Presentation non-GAAP v2.pdf
Reconciliation to Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/resources/POL%2520CFA%2520IR%2520Presentation%2520w%2520non%2520GAAP%252011%252019%25202013.pdf
Strong past performance demonstrates that our
strategy and execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation
and competitive advantage
• Strong and proven management team driving
growth and performance
• Addressable market exceeds $40 billion
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Page 14
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and
presented in accordance with U.S.
Average Debt Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average
PolyOne Debt $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 987.7 $ 897.3
Average Equity Q3 2012 Q4 2012 Q1 2013 Q2 2013 Q3 2013 Average
PolyOne shareholders’ equity $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 996.6 $ 824.1
Reconciliation to Condensed Consolidated Balance Sheets YTD 2013
Short-term debt and current portion of long-term debt $ 9.9
Long-term debt 977.8
Less cash and cash equivalents (322.8)
Net debt $ 664.9
Adjusted EBITDA Q4 2012 Q1 2013 Q2 2013 Q3 2013 Total
PolyOne Income before income taxes $ (1.1) $ 15.7 $ 62.9 $ 38.8 $ 116.3
PolyOne Interest expense, net 13.7 15.6 16.6 16.0 61.9
PolyOne Depreciation and amortization 15.5 19.0 25.8 30.3 90.6
PolyOne Special items in EBITDA 26.5 27.7 (5.2) 11.2 60.2
PolyOne Adjusted EBITDA 54.6 78.0 100.1 96.3 329.0
Pro forma Spartech EBITDA 14.7 11.2 - - 25.9
Pro forma EBITDA $ 69.3 $ 89.2 $ 100.1 $ 96.3 $ 354.9
CFA Society Cleveland �Midwest Investment Conference 2013��PolyOne Investor Presentation �November 19, 2013�
Forward – Looking Statements
Use of Non-GAAP Measures
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Innovation Drives Earnings Growth
We are Experts in Polymer Science and Formulation
Positioned for Strong Growth
Q3 2013 Financial Highlights
Debt Maturities & Liquidity Summary – 9/30/13
Use of Cash
Why Invest In PolyOne?
ADP35C9.tmp
Reconciliation to Condensed Consolidated Balance Sheets
https://www.avient.com/sites/default/files/2023-12/Avient_ALL_Policies_Dec_18_2023.pdf
Ashish Khandpur
President and CEO
December 18, 2023
SAFETY & HEALTH POLICY
Avient Corporation believes that safety and health are the highest corporate priority.
As a member
of the American Chemistry Council, we have adopted Responsible Care® Guiding
Principles and the Process Safety Management Practices to continuously guide our
efforts to improve safety performance.
Our
practices reinforce these imperatives, and our commitment to excellence in safety
and health is absolute.
https://www.avient.com/sites/default/files/2021-11/avnt-november-investor-meetings.pdf
We are better together through:
Keeping Safety First — PolyOne and Clariant are both ACC Responsible Care® companies,
and nothing is more important than the health, safety and well-being of our people.
We are Avient.
6
BETTER TOGETHER: POLYONE AND
CLARIANT COLOR
Key Financial Data (1)
2021E Sales $4.75 billion
2021E EBITDA $580 million
87% of EBITDA from specialty applications
(1) As of October 28, 2021 webcast
Synergies
($ millions)
Three-Year
Estimate
Administrative $ 20
Sourcing 30
Operational 25
Total Synergies $ 75
CLARIANT COST SYNERGIES
• On-track to realize $50 million of expected
synergies in 2021 – up from earlier estimate of $35
million
• Relentless focus on guiding principles for
acquisition integration: safety first, employee
collaboration and exceeding customer expectations
• Future revenue synergies in excess of $50 million
by 2025 are not part of these estimates and
represent additional growth over the long term
8
• Barrier technology
• Functional additives
• Processing aids
• Flame retardants
• Light-weighting
additives
Complementary
Technologies
• Clariant’s approved
formulations and
certified facilities
• Legacy PolyOne’s
leading share in
distribution channels
Healthcare
Solutions
• Clariant’s position
in SE Asia,
Latin America,
Germany & Italy
• Legacy PolyOne’s
position in U.S.,
Canada and China
Regional
Strengths
• Solutions with Avient’s
engineered materials
customers
• Avient’s distribution
channels
Segment
Cross-selling
COMPLEMENTARY TECHNOLOGIES AND
CUSTOMERS DRIVE REVENUE SYNERGIES
Revenue synergy opportunities in excess of $50M by 2025
The complementary aspects of our combined businesses are unquestionable.
APPENDIX
Performance
Additives
Pigments
TiO2
Dyestuffs
4%Polyethylene
Nylon
Polypropylene
Other Raw
Materials
29%
Styrenic Block
Copolymer
~1/3 hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
36
• Significant raw material price inflation and
tight inventory continued in Q3 2021
o Average cost of hydrocarbon based
materials was up 65% year-over-year and
10% sequentially
o Average cost of non-hydrocarbon based
materials was up 20% year-over-year and
3% sequentially
• Additionally, we continued to experience
other supply chain challenges during Q3
related to raw material spot purchases,
freight constraints and productivity loss
as a result of these shortages
Annual Purchases
RAW MATERIAL AND SUPPLY CHAIN UPDATE
Based on 2020 pro forma purchases, excludes Distribution business
SEGMENT DATA
U.S. & Canada
51%
Latin America
2021 YTD SEGMENT, END MARKET AND GEOGRAPHY
38
GEOGRAPHY REVENUESEGMENT FINANCIALS
23%
19%
Building and
END MARKET REVENUE
(1) Total company sales and EBITDA of $3,617M and $455M, respectively, include intercompany sales eliminations and corporate costs
All charts reflect YTD financials through September 30
$1,820M
$321M
$691M
$127M
$1,206M
$72M
Sales Adjusted EBITDA
Distribution
Specialty Engineered Materials
Color Additives and Inks
$455M$3,617M
34%
21%
7%
Building &
9%
2% Telecommunications
C O L O R , A D D I T I V E S & I N K S
2021 YTD REVENUE | $1 .8 BILL ION
31%
42%
21%
Latin America
END MARKET REGION
39
S P E C I A LT Y E N G I N E E R E D M AT E R I A L S
28%
11%
Building &
7%
2021 YTD REVENUE | $691 MILLION
END MARKET
55%
20%
REGION
40
DI S TR IBU T I ON
26%
22%
20%
Building and
81%
Latin
America
END MARKET REGION
K E Y S U P P L I ER S
2021 YTD REVENUE | $1 .2 BILL ION
41
TOTA L C O M PA N Y R E G I O N A L S A L E S
BY END MARKET
30%
27%
Building &
2% Energy
(16% of sales)
31%
17%
Building &
(25% of sales)
42
19%
17%
Building &
US &
Canada
(51% of sales)
13%
42%
33%
3%
Building &
LATAM
(8% of sales)
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
September 30, 2021
Reconciliation to Condensed Consolidated Statements of Income
GAAP
Special
Adjusted
Operating income $ 78.7 $ 20.0 $ 98.7
Income from continuing operations before income taxes $ 61.1 $ 19.9 $ 81.0
Income tax expense - GAAP (8.5) — (8.5)
Income tax impact of special items — (4.6) (4.6)
Tax adjustments — (3.6) (3.6)
Net income attributable to noncontrolling interests 0.3 — 0.3
Net income from continuing operations attributable to Avient shareholders $ 52.9 $ 11.7 $ 64.6
Net income / EPS $ 0.57 $ 0.13 $ 0.70
Weighted-average diluted shares 92.2 92.2 92.2
September 30, 2020
Reconciliation to Condensed Consolidated Statements of Income
GAAP
Special
Adjusted
Operating income $ 33.5 $ 40.4 $ 73.9
Income from continuing operations before income taxes $ 5.3 $ 50.0 $ 55.3
Income tax expense - GAAP (2.7) — (2.7)
Income tax impact of special items — (12.7) (12.7)
Tax adjustments — 3.0 3.0
Net income attributable to noncontrolling interests (0.9) — (0.9)
Net income from continuing operations attributable to Avient shareholders $ 1.7 $ 40.3 $ 42.0
Net income / EPS $ 0.02 $ 0.44 $ 0.46
Weighted-average diluted shares 91.9 91.9 91.9
Three Months Ended
Three
Months
Nine
Months
Year Ended
December 31,
Reconciliation to Pro Forma
Adjusted EBITDA 2021 2020
June 30,
2021
September
30, 2021 2020 2019 2018
Net income from continuing
operations – GAAP $ 52.6 $ 2.6 $ 69.4 $ 201.7 $ 133.8 $ 75.7 $ 87.4
Income tax expense 8.5 2.7 20.4 51.8 5.2 33.7 14.4
Interest expense 19.0 29.7 19.5 57.8 74.6 59.5 62.8
Debt extinguishment cost — — — — — — 1.1
Depreciation and amortization from
continuing operations 36.8 36.5 33.8 107.7 115.0 78.1 72.6
EBITDA $ 116.9 71.5 $ 143.1 $ 419.0 $ 328.6 $ 247.0 $ 238.3
Special items, before tax 19.9 50.0 14.2 36.5 66.2 61.7 59.5
Interest expense included in special
items — (9.6) — — (10.1) — —
Depreciation and amortization
included in special items (0.9) (1.3) 1.4 (0.1) (3.2) — (3.0)
Adjusted EBITDA $ 135.9 $ 110.6 $ 158.7 $ 455.4 $ 381.6 $ 308.7 $ 294.8
Clariant MB pro forma adjustments(1) — — — — 75.1 133.2 141.5
Pro forma adjusted EBITDA $ 135.9 $ 110.6 $ 158.7 $ 455.4 $ 456.7 $ 441.9 $ 436.3
(1) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition
Reconciliation of EBITDA by Segment
Nine Months
December 31,
2021 2020 2021 2020 2019 2018
Sales:
Color, Additives and Inks $ 586.6 $ 493.8 $ 1,820.3 $ 1,502.9 $ 1,003.8 $ 1,046.5
Specialty Engineered Materials 233.6 174.1 690.7 708.8 745.7 645.8
Distribution 438.8 276.9 1,205.9 1,110.3 1,192.2 1,265.4
Corporate and eliminations (39.2) (20.3) (99.6) (79.9) (79.0) (76.7)
Sales $ 1,219.8 $ 924.5 $ 3,617.3 $ 3,242.1 $ 2,862.7 $ 2,881.0
Operating income:
Color, Additives and Inks $ 66.8 $ 50.5 $ 241.9 $ 180.8 $ 147.4 $ 158.5
Specialty Engineered Materials 31.7 24.7 103.2 94.4 83.7 72.3
Distribution 23.8 17.5 71.5 69.5 75.4 71.5
Corporate and eliminations (43.6) (59.2) (109.4) (155.4) (149.7) (123.7)
Operating income $ 78.7 $ 33.5 $ 307.2 $ 189.3 $ 156.8 $ 178.6
Items below OI in Corporate:
Other income, net $ 1.4 $ 1.5 $ 4.1 $ 24.3 $ 12.1 $ (12.9)
Depreciation & amortization:
Color, Additives and Inks $ 26.6 $ 26.3 $ 79.2 $ 75.1 $ 42.7 $ 44.3
Specialty Engineered Materials 7.9 7.5 23.8 30.0 29.5 23.2
Distribution 0.2 0.2 0.6 0.7 0.5 0.7
Corporate and eliminations 2.1 2.5 4.1 9.2 5.4 4.4
Depreciation & Amortization $ 36.8 $ 36.5 $ 107.7 $ 115.0 $ 78.1 $ 72.6
EBITDA:
Color, Additives and Inks $ 93.4 $ 76.8 $ 321.1 $ 255.9 $ 190.1 $ 202.8
Specialty Engineered Materials 39.6 32.2 127.0 124.4 113.2 95.5
Distribution 24.0 17.7 72.1 70.2 75.9 72.2
Corporate and eliminations (41.5) (56.7) (105.3) (146.2) (144.3) (119.3)
EBITDA $ 116.9 $ 71.5 $ 419.0 $ 328.6 $ 247.0 $ 238.3
EBITDA as a % of Sales:
Color, Additives and Inks 15.9 % 15.6 % 17.6 % 17.0 % 18.9 % 19.4 %
Specialty Engineered Materials 17.0 % 18.5 % 18.4 % 17.6 % 15.2 % 14.8 %
Distribution 5.5 % 6.4 % 6.0 % 6.3 % 6.4 % 5.7 %
Reconciliation of Pro Forma EBITDA - Color, Additives and Inks
Year Ended
December 31,
2020 2019 2018
Sales:
Color, Additives and Inks $ 1,502.9 $ 1,003.8 $ 1,046.5
Clariant MB pro forma
adjustments(1) 540.4 1,118.6 1,209.8
Pro forma sales $ 2,043.3 $ 2,122.4 $ 2,256.3
Operating income:
Color, Additives and Inks $ 180.8 $ 147.4 $ 158.5
Clariant MB pro forma
adjustments(1) 45.0 72.9 80.3
Pro forma operating income $ 225.8 $ 220.3 $ 238.8
Depreciation & amortization:
Color, Additives and Inks $ 75.1 $ 42.7 $ 44.3
Clariant MB pro forma adjustments(1) 30.1 60.3 61.2
Pro forma depreciation & amortization $ 105.2 $ 103.0 $ 105.5
EBITDA
Color, Additives and Inks $ 255.9 $ 190.1 $ 202.8
Clariant MB pro forma
adjustments(1) 75.1 133.2 141.5
Pro forma EBITDA $ 331.0 $ 323.3 $ 344.3
Pro forma EBITDA as a % of Sales 16.2 % 15.2 % 15.3 %
December 31, 2020
Reconciliation of Pro Forma Adjusted
Earnings per Share Avient
Special
Adjusted
Clariant MB
Pro Forma
Adjustments(1)
Pro Forma
Adjusted
Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5
Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0
Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6)
Other income, net 24.3 (17.6) 6.7 — 6.7
Income taxes (5.2) (41.4) (46.6) (6.2) (52.8)
Net income attributable to noncontrolling
interests (1.8) — (1.8) — (1.8)
Net income from continuing operations
attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5
Weighted average diluted shares 90.6
Impact to diluted shares from January 2020 equity offering 1.5
Pro forma weighted average diluted shares 92.1
Pro forma adjusted EPS $ 1.93
December 31, 2019
Reconciliation of Pro Forma Adjusted
Earnings per Share Avient
Special
Adjusted
Clariant MB
Pro Forma
Adjustments(1)
Pro Forma
Adjusted
Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3
Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4
Interest expense, net (59.5) — (59.5) (33.4) (92.9)
Other income, net 12.1 (10.0) 2.1 — 2.1
Income taxes (33.7) (5.9) (39.6) (9.1) (48.7)
Net income attributable to noncontrolling
interests (0.2) — (0.2) — (0.2)
Net income from continuing operations
attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7
Weighted average diluted shares 77.7
Impact to diluted shares from January 2020 equity offering 15.3
Pro forma weighted average diluted shares 93.0
Pro forma adjusted EPS $ 1.74
AVNT November Investor Meetings.pdf
AVNT Q3 2021 Earnings Presentation.pdf
Final 10.27 606pm Q3 21 IR Deck Version v1.pdf
https://www.avient.com/sites/default/files/2022-05/Avient_ALL_Policies_2022_0.pdf
Bob Patterson
Chairman, President, and CEO
February 2, 2022
SAFETY & HEALTH POLICY
Avient Corporation believes that safety and health are the highest corporate priority.
As a member
of the American Chemistry Council, we have adopted Responsible Care® Guiding
Principles and the Process Safety Management Practices to continuously guide our
efforts to improve safety performance.
Our
practices reinforce these imperatives, and our commitment to excellence in safety
and health is absolute.
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
We are better together through:
Keeping Safety First — PolyOne and Clariant are both ACC Responsible Care® companies,
and nothing is more important than the health, safety and well-being of our people.
We are Avient.
4
BETTER TOGETHER: POLYONE AND
CLARIANT MASTERBATCH
Key Data
2020 PF Sales
$3.7 billion
2020 PF EBITDA
$440 million ($515M w/synergies)
2020E Free Cash Flow $270 million
(1) Estimated Pro forma for the acquisition of the Clariant Masterbatch business
87% of EBITDA from specialty applications
U.S. & Canada
49%
25%
17%
Latin America
SEGMENT, END MARKET AND GEOGRAPHY
5
GEOGRAPHY REVENUESEGMENT FINANCIALS
21%Industrial
Building &
Electrical &
END MARKET REVENUE
All data reflects 2020 estimate and Pro forma for acquisition of the Clariant Masterbatch business
It’s why we win.
11
474
644
925
107
147
212
467
616
858
2014 2018 2020PF
R&D / Technical Marketing Sales
Commercial Resources
+ 36%
+ 37%
+ 32%
+ 44%
+ 44%
+ 39%
Headcount figures are Pro forma for the sale of Designed Structures and Solutions (DSS) and Performance Products and Solutions (PP&S)
segments and the acquisition of the Clariant Masterbatch business. 2020PF data as of October 31, 2020.